Literature DB >> 3965743

Detection of immunologically cross-reacting capsid protein of alphaviruses on the surfaces of infected L929 cells.

C Smith, J A Wolcott, C J Wust, A Brown.   

Abstract

Hyperimmune, but not normal immune, monospecific antiserum made to capsid protein of Sindbis virus (SIN) was found to cause cytolysis equally well of both SIN- and Semliki Forest virus-infected L929 cells in antibody-dependent, complement-mediated cytotoxicity assays. The cell surface reactivity of the hyperimmune antiserum was also demonstrated by solid-phase radioimmune assays with unfixed infected cells or infected cells fixed with low concentrations of glutaraldehyde (0.025%) before reactivity with antisera. Higher concentrations of glutaraldehyde lowered the sensitivity of detection. Purified SIN capsid protein specifically inhibited antibody-dependent, complement-mediated cytotoxicity by the monospecific anti-capsid protein serum on SIN- and Semliki Forest virus-infected target cells. That hyperimmune anti-SIN serum also cross-reacts with capsid protein on the surface of Semliki Forest virus-infected cells was suggested by the fact that capsid protein inhibited cross-cytolysis in the antibody-dependent, complement-mediated cytotoxicity assay. The latter antiserum was collected after repeated injections of purified virions over a 9-month period. The results suggest that hyperimmune monospecific antisera made to SIN capsid protein or hyperimmune antisera to SIN or Semliki Forest virions detect homologous and cross-reacting capsid protein determinants on the surface of infected cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965743      PMCID: PMC255008     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Sequential translation of capsid and membrane protein genes of alphaviruses.

Authors:  J C Clegg
Journal:  Nature       Date:  1975-04-03       Impact factor: 49.962

2.  Initiation of synthesis of the structural proteins of Semliki Forest virus.

Authors:  J C Clegg; S I Kennedy
Journal:  J Mol Biol       Date:  1975-10-05       Impact factor: 5.469

3.  Envelopments of Sindbis virus: synthesis and organization of proteins in cells infected with wild type and maturation-defective mutants.

Authors:  J F Smith; D T Brown
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

4.  A simple procedure for removal of Triton X-100 from protein samples.

Authors:  P W Holloway
Journal:  Anal Biochem       Date:  1973-05       Impact factor: 3.365

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells.

Authors:  J L Virelizier; A C Allison; J S Oxford; G C Schild
Journal:  Nature       Date:  1977-03-03       Impact factor: 49.962

7.  Tapping the immunological repertoire to produce antibodies of predetermined specificity.

Authors:  R A Lerner
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

8.  A viral polymerase involved in recognition of influenza virus-infected cells by a cytotoxic T-cell clone.

Authors:  J R Bennink; J W Yewdell; W Gerhard
Journal:  Nature       Date:  1982-03-04       Impact factor: 49.962

9.  The specificity of effector T cells activated by tumours induced by murine oncornaviruses.

Authors:  G R Shellam; R A Knight; N A Mitchison; R M Gorczynski; A Maoz
Journal:  Transplant Rev       Date:  1976

10.  Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses.

Authors:  R B Effros; P C Doherty; W Gerhard; J Bennink
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

View more
  1 in total

1.  Expression of Sindbis virus structural proteins via recombinant vaccinia virus: synthesis, processing, and incorporation into mature Sindbis virions.

Authors:  C M Rice; C A Franke; J H Strauss; D E Hruby
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.